Ken Griffin Organovo Holdings, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Organovo Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 18,800 shares of ONVO stock, worth $8,460. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,800
Previous 16,200
16.05%
Holding current value
$8,460
Previous $16,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ONVO
# of Institutions
36Shares Held
2.33MCall Options Held
18.8KPut Options Held
0-
Armistice Capital, LLC New York, NY929KShares$418,0500.01% of portfolio
-
Prescott Group Capital Management, L.L.C. Tulsa, OK474KShares$213,3010.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA354KShares$159,1250.0% of portfolio
-
Black Rock Inc. New York, NY142KShares$63,9930.0% of portfolio
-
Geode Capital Management, LLC Boston, MA110KShares$49,6630.0% of portfolio
About ORGANOVO HOLDINGS, INC.
- Ticker ONVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,712,020
- Market Cap $3.92M
- Description
- Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...